Table 1_Risk factors for disease generalization in acetylcholine receptor antibody-positiv

85 patients with ocular-onset myasthenia gravis were studied to identify predictors of progression to generalized disease. The dataset likely contains demographic, clinical, electrophysiological, and serological data from a multicenter retrospective cohort. It was authored by Lorenzo Verriello and shared on figshare in 2026.

Use Cases

• Predicting progression to generalized myasthenia gravis based on antibody titers
• Assessing clinical risk stratification based on electrophysiological results
• Training models to identify high-risk patients for early therapeutic intervention
• Validating prognostic factors for ocular myasthenia gravis in a retrospective cohort

Strengths

• Includes data from 85 patients across three neurology centers
• Analyzes multiple data types: demographic, clinical, electrophysiological, and serological

Limitations

• Row count is unknown, which may limit suitability assessment
• Column-level documentation is absent; field semantics must be inferred after download

Provenance

Source

figshare

Collection Method

Multicenter retrospective cohort study

Freshness

Last updated 2026-05-25 04:32:49

Geography

Italy (three Italian neurology centers)